Companies · Biotechnology

Orthopedic Driven Imaging, LLC

MISSOULA · Biotechnology

Diligence memoA one-page analyst read on Orthopedic Driven Imaging, LLC — recommendation, valuation, rhythm, risks.
$3.5M
Total raised · real
2
Rounds
3.7×
Latest step-up
Top 64%
Sector rank · raised
Seed
Latest stage · inferred · Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

Orthopedic Driven Imaging, LLC looks over-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the biotech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 1.81× the median modeled value of Seed Biotechnology companies in 2025–2027 (99 peers) — value vs value, same stage and era.
Active
  • Last raise 14 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Orthopedic Driven Imaging, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
2.3 yr record
Peak capital year was 2025 with $2.8M across 1 filings.
Market position
ahead of 37% of Biotechnology peers
Capital scale is ahead of 37% of Biotechnology peers; modeled value is above 16% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2025: $2.8M across 1 filings.
  • Largest single filing was $2.8M on 2025-05-13.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Biotechnology

Orthopedic Driven Imaging, LLC is one of 4291 Biotechnology companies tracked from MISSOULA. By capital raised it ranks in the long tail (ahead of 37% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2023
Year incorporated
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$2.5M$5.0M$7.5M$10MPre-Seed · 2024-03-29 Raised $750K (real) Modeled valuation $4.1M (est)$750K$4.1MPre-Seed2024Seed · 2025-05-13 Raised $2.8M (real) Modeled valuation $8.2M (est)$2.8M$8.2MSeed2025+$2.8MCumulative $3.5M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$750K · 2024
Seed$2.8M · 2025

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$8.2M
Base estimate est.
$2.0M
Conservative case
$17.4M
Upside case
$13.8M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the biotech sector profile. Directional, not a quoted figure.

Pre-Seed · modeled $4.1M · 2024-03-292024Seed · modeled $8.2M · 2025-05-132025
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
32%
Survival probability
14% low · 50% high
1.74×/yr
Annual markup
2.28×/yr upside case
1.1 yr
Elapsed time used
1.1 yr actual, capped for stale marks
biotech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
13 mo
Avg between rounds
$3.1M/yr
Capital velocity
2.3 yr
On record since
2024
First round
2
Rounds on file
How it compares to the market

Benchmarked against 4291 companies in Biotechnology. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.5× of median
This company$3.5M
Sector median$7.2M
Latest round — vs other Seed rounds in sector (real $, this stage) 1.6× above median
This company$2.8M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.1× of median
This company$8.2M
Sector median$64.2M

Raised more than 37% of sector peers (real $). Modeled value above 16% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #15 of 99.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0MCapital raised (log)Carna Inc. · Seed Raised $3.4M · modeled $12.4M (est)NRX Pharmaceuticals, Inc. · Seed Raised $3.5M · modeled $12.3M (est)Vicora, Inc. · Seed Raised $3.4M · modeled $11.9M (est)MH3D, Inc. · Seed Raised $3.3M · modeled $11.9M (est)Oral Genome Corp. · Seed Raised $3.1M · modeled $11.2M (est)Synlico Inc. · Seed Raised $5.2M · modeled $10.1M (est)Auxilium Biotechnologies Inc. · Seed Raised $7.2M · modeled $9.7M (est)Silexion Therapeutics Corp · Seed Raised $3.6M · modeled $9.6M (est)Bodark Investment Group LP · Seed Raised $3.3M · modeled $9.4M (est)Sower Solas I Sidecar III, LLC · Seed Raised $3.5M · modeled $9.3M (est)Sift Biosciences, Inc. · Seed Raised $3.8M · modeled $8.4M (est)SiVEC Biotechnologies, Inc. · Seed Raised $3.3M · modeled $8.4M (est)Orthopedic Driven Imaging, LLC (this company) Raised $3.5M · modeled $8.2M (est)Orthopedic Driven Imaging, LLC
CompanyStageRaised · realValue · estvs peer med.
Carna Inc.Seed$3.4M$12.4M2.72×
NRX Pharmaceuticals, Inc.Seed$3.5M$12.3M2.70×
Vicora, Inc.Seed$3.4M$11.9M2.61×
MH3D, Inc.Seed$3.3M$11.9M2.61×
Oral Genome Corp.Seed$3.1M$11.2M2.45×
Synlico Inc.Seed$5.2M$10.1M2.22×
Auxilium Biotechnologies Inc.Seed$7.2M$9.7M2.13×
Silexion Therapeutics CorpSeed$3.6M$9.6M2.10×
Bodark Investment Group LPSeed$3.3M$9.4M2.06×
Sower Solas I Sidecar III, LLCSeed$3.5M$9.3M2.05×
Sift Biosciences, Inc.Seed$3.8M$8.4M1.85×
SiVEC Biotechnologies, Inc.Seed$3.3M$8.4M1.85×
Orthopedic Driven Imaging, LLC this companySeed$3.5M$8.2M1.81×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$750K2024-03-29$4.2M$4.1M90%
Seed$2.8M2025-05-13$13.8M$8.2M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$750K2024-03-29
    • First recorded raise — entered as Pre-Seed.
    • 1 investor on this round.
  2. Seed$2.8M2025-05-13
    • Raised 13 mo later, in step with the ~14 mo sector norm.
    • Round 3.7× larger than the prior — scaling up.
Intelligence
2026 ~Q2
Modeled next raise · ~13mo cadence
$8.3M
Modeled next size est.range $5.4M$13.2M
3.7×
Last step-up
$3.1M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Donald Running4 other2024-03
Daniel Justin1 other2025-05
Scott Banks2024-03
Registry & provenance

Orthopedic Driven Imaging, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
2019000
SEC CIK
2023
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Arthrotak, LLCBiotechnologySeed$1.5M$4.5Mnetwork2 shared operators · same sector · same stage
Magnesium Development Company, LLCBiotechnologySeed$2.5M$108.8Mnetwork1 shared operator · same sector · same stage
BioTraceIT CorpBiotechnologySeed$3.5M$5.6Msame sector · same stage
Equon Pharmaceuticals, Inc.BiotechnologySeed$3.5M$5.6Msame sector · same stage
Gpn Vaccines, Inc.BiotechnologySeed$3.5M$7.5Msame sector · same stage
Molecuvax IncBiotechnologySeed$3.5M$5.6Msame sector · same stage
Sower Solas I Sidecar III, LLCBiotechnologySeed$3.5M$9.3Msame sector · same stage
Edesa Biotech, Inc.BiotechnologySeed$3.5M$5.6Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Strive Orthopedics, Inc.BiotechnologyPre-Seed$27.6M88%
Bone Health Technologies, Inc.BiotechnologySeed$29.8M86%
Osteonovus, Inc.BiotechnologySeed$47.7M83%
Emit Imaging, Inc.BiotechnologySeries A$33.5M83%
Microstructure Imaging, Inc.BiotechnologyPre-Seed$4.8M83%
Spineology IncBiotechnologySeries B$34.9M83%
Threat Assessment Imaging, Inc.BiotechnologyPre-Seed$8.3M83%
Arthrotak, LLCBiotechnologySeed$4.5M83%
Frequently asked
How much funding has Orthopedic Driven Imaging, LLC raised?
Orthopedic Driven Imaging, LLC has raised approximately $3.5M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Orthopedic Driven Imaging, LLC's estimated valuation?
Provath's modeled valuation for Orthopedic Driven Imaging, LLC is approximately $8.2M (modeled range $2.0M–$17.4M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Orthopedic Driven Imaging, LLC at?
Orthopedic Driven Imaging, LLC's latest modeled financing stage is Seed. Its most recent recorded round closed around Tue May 13.
What does Orthopedic Driven Imaging, LLC do and where is it based?
Orthopedic Driven Imaging, LLC operates in the Biotechnology sector, based in MISSOULA.
Explore related

See where Orthopedic Driven Imaging, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Orthopedic Driven Imaging, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.